Long‐term outcome after COVID ‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study

Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis

(2022) Lavienraj Premraj et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

(2021) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Attributes and predictors of long COVID

(2021) Carole H. Sudre et al.   NATURE MEDICINE

Diverse Functional Autoantibodies in Patients with COVID-19

(2021) Eric Y. Wang et al.   NATURE

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry

(2021) Gabriel Bsteh et al.   PLoS One

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

(2021) Mahdi Barzegar et al.   Multiple Sclerosis and Related Disorders

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

(2021) Afagh Garjani et al.   Multiple Sclerosis and Related Disorders

DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France

(2021) Maria Pia Sormani et al.   Annals of Clinical and Translational Neurology

COVID-19 Among Patients With Multiple Sclerosis

(2021) Mahdi Barzegar et al.   Neurology-Neuroimmunology & Neuroinflammation

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study

(2021) Gabriel Bsteh et al.   Multiple Sclerosis Journal

COVID-19 Severity in Multiple Sclerosis

(2021) Maria Pia Sormani et al.   Neurology-Neuroimmunology & Neuroinflammation

Recovery From COVID-19 in Multiple Sclerosis

(2021) Afagh Garjani et al.   Neurology-Neuroimmunology & Neuroinflammation

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

(2020) Céline Louapre et al.   JAMA Neurology

Multiple sclerosis and COVID‐19: how many are at risk?

(2020) G. Bsteh et al.   EUROPEAN JOURNAL OF NEUROLOGY

The role of infections in multiple sclerosis

(2019) Mariano Marrodan et al.   Multiple Sclerosis Journal

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Uhthoff's phenomena in MS—clinical features and pathophysiology

(2013) Teresa C. Frohman et al.   Nature Reviews Neurology